Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Central fatigue in multiple sclerosis: a review of the literature.
FDA product review for daclizumab
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Mechanism of action for leflunomide in rheumatoid arthritis.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Biomarkers of disease activity in multiple sclerosis.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Ampyra (Fampyra)
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Interferon-beta is a potent promoter of nerve growth factor production by astrocytes.
CHMP determines dimethyl fumarate in TECFIDERA® to be a new active substance in the European Union
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.
Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS.
EU regulator warns on possible MS drugs side effects
Multiple sclerosis review.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.

Pages